Director Deals - (ADT1)

Paul Cronin, Chief Executive Officer, exercised 750,000 shares in the company on the 8th January 2020 at a price of 1.34p. The Director now holds...

Thu, 09/01/2020 - 09:00


Broker Forecast - Liberum Capital issues a broker note on Balfour Beatty PLC

Liberum Capital today reaffirms its buy investment rating on Balfour Beatty PLC (LON:BBY) and raised its price target to 400p (from 350p).

Broker Forecasts data...

Thu, 09/01/2020 - 09:00


Central Asia Metals hails strong 'year' as copper output tops guidance

Central Asia Metals hailed a 'strong' year of after copper output topped guidance and zinc and lead production was delivered at the top end of...

Thu, 09/01/2020 - 08:56


Broker Forecast - Deutsche Bank issues a broker note on Aston Martin Lagonda

Deutsche Bank today reaffirms its hold investment rating on Aston Martin Lagonda (LON:AML) and cut its price target to 400p (from 560p).

Broker Forecasts data...

Thu, 09/01/2020 - 08:50


Impact Healthcare REIT acquires care home for £3m

Impact Healthcare REIT said it had acquired a care home for £3m.

The company appointed one of its existing tenants, Minster Care Management, as the...

Thu, 09/01/2020 - 08:44


Columbus Energy completes drilling of Saffron well in Trinidad

Oil and gas producer and explorer Columbus Energy said it had completed drilling at its Saffron well, onshore Trinidad, and aimed to carry out all...

Thu, 09/01/2020 - 08:42


Broker Forecast - Deutsche Bank issues a broker note on Ferrexpo PLC

Deutsche Bank today reaffirms its hold investment rating on Ferrexpo PLC (LON:FXPO) and cut its price target to 160p (from 200p).

Broker Forecasts data provided...

Thu, 09/01/2020 - 08:40


Broker Forecast - Deutsche Bank issues a broker note on Rio Tinto PLC

Deutsche Bank today reaffirms its hold investment rating on Rio Tinto PLC (LON:RIO) and raised its price target to 4450p (from 4400p).

Broker Forecasts data...

Thu, 09/01/2020 - 08:30


Itaconix revenues jump 60% amid ongoing momentum

Itaconix said annual revenues jumped 60% amid ongoing momentum across all of its products and application areas.

Unaudited revenues for the year grew 69.6% to...

Thu, 09/01/2020 - 08:30


Hikma Pharmaceuticals teams up with Arecor to develop 'ready-to-use' injectable medicine in US

Hikma Pharmaceuticals said it had entered into an exclusive agreement with Arecor to co-develop a ready-to-use injectable medicine in the US.

Under the terms of...

Thu, 09/01/2020 - 08:24


Pages